1apy

From Proteopedia

Revision as of 12:09, 18 December 2007 by OCA (Talk | contribs)
Jump to: navigation, search

1apy, resolution 2.0Å

Drag the structure with the mouse to rotate

HUMAN ASPARTYLGLUCOSAMINIDASE

Contents

Overview

The high resolution crystal structure of human lysosomal, aspartylglucosaminidase (AGA) has been determined. This lysosomal enzyme, is synthesized as a single polypeptide precursor, which is immediately, post-translationally cleaved into alpha- and beta-subunits. Two alpha- and, beta-chains are found to pack together forming the final heterotetrameric, structure. The catalytically essential residue, the N-terminal threonine, of the beta-chain is situated in the deep pocket of the funnel-shaped, active site. On the basis of the structure of the enzyme-product complex, we present a catalytic mechanism for this lysosomal enzyme with an, exceptionally high pH optimum. The three-dimensional structure also allows, the prediction of the structural consequences of human mutations resulting, in aspartylglucosaminuria (AGU), a lysosomal storage disease.

Disease

Known disease associated with this structure: Aspartylglucosaminuria OMIM:[208400]

About this Structure

1APY is a Single protein structure of sequence from Homo sapiens with NAG as ligand. Active as N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, with EC number 3.5.1.26 Known structural/functional Sites: and . Full crystallographic information is available from OCA.

Reference

Three-dimensional structure of human lysosomal aspartylglucosaminidase., Oinonen C, Tikkanen R, Rouvinen J, Peltonen L, Nat Struct Biol. 1995 Dec;2(12):1102-8. PMID:8846222

Page seeded by OCA on Tue Dec 18 14:19:24 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools